| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00018-017-2486-0 |
| P698 | PubMed publication ID | 28246701 |
| P50 | author | Ho-Chang Jeong | Q86654739 |
| Hyuk-Jin Cha | Q60994696 | ||
| P2093 | author name string | Seung-Ju Cho | |
| Mi-Ok Lee | |||
| P2860 | cites work | Geron trial resumes, but standards for stem cell trials remain elusive | Q85190781 |
| Chemical ablation of tumor-initiating human pluripotent stem cells | Q87373925 | ||
| Live-cell imaging of human pluripotent stem cells by a novel lectin probe rBC2LCN | Q87560415 | ||
| Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency | Q42811272 | ||
| Selective ablation of human embryonic stem cells expressing a "suicide" gene | Q44438602 | ||
| In vitro detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human induced pluripotent stem cells. | Q45868109 | ||
| Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells. | Q45980241 | ||
| Stem-cell pioneer bows out. | Q46343335 | ||
| Development of a decoy immunization strategy to identify cell-surface molecules expressed on undifferentiated human embryonic stem cells | Q46534544 | ||
| Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke | Q48262046 | ||
| GRNOPC1: the world's first embryonic stem cell-derived therapy. Interview with Jane Lebkowski | Q48433072 | ||
| Geron gets green light for human trial of ES cell-derived product | Q50600513 | ||
| Intact wound repair activity of human mesenchymal stem cells after YM155 mediated selective ablation of undifferentiated human embryonic stem cells. | Q51010002 | ||
| The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. | Q51791870 | ||
| Cytotoxicity of ganciclovir on cultured human corneal endothelial cells. | Q53117760 | ||
| Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches. | Q53495297 | ||
| Embryonic and induced pluripotent stem cell staining and sorting with the live-cell fluorescence imaging probe CDy1 | Q57691951 | ||
| Selective Elimination of Human Pluripotent Stem Cells by a Marine Natural Product Derivative | Q58449673 | ||
| Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation | Q24563808 | ||
| Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine | Q24646217 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies | Q28252926 | ||
| Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen | Q28283278 | ||
| Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium | Q28305306 | ||
| Embryonic stem cell trials for macular degeneration: a preliminary report | Q29620714 | ||
| Real-time label-free monitoring of adipose-derived stem cell differentiation with electric cell-substrate impedance sensing | Q30475736 | ||
| Human embryonic stem cells derived by somatic cell nuclear transfer. | Q30544785 | ||
| Laser-assisted photoablation of human pluripotent stem cells from differentiating cultures | Q33534725 | ||
| 'Above all, do no harm': safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis | Q33826992 | ||
| Effects of cell number on teratoma formation by human embryonic stem cells | Q33835956 | ||
| High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis. | Q33944653 | ||
| A small molecule inhibitor of redox-regulated protein translocation into mitochondria | Q34036402 | ||
| A chemical probe that labels human pluripotent stem cells | Q34040110 | ||
| Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein | Q34043742 | ||
| An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells | Q34044130 | ||
| Development of an inducible caspase-9 safety switch for pluripotent stem cell-based therapies | Q34044181 | ||
| A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy | Q34044757 | ||
| Survival responses of human embryonic stem cells to DNA damage | Q34078474 | ||
| Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes | Q34103739 | ||
| A fluorescent rosamine compound selectively stains pluripotent stem cells | Q34135855 | ||
| Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells | Q34278003 | ||
| Lessons from human teratomas to guide development of safe stem cell therapies. | Q34298868 | ||
| Inhibition of pluripotent stem cell-derived teratoma formation by small molecules | Q34362039 | ||
| High-throughput tracking of pluripotent human embryonic stem cells with dual fluorescence resonance energy transfer molecular beacons | Q34422397 | ||
| Escape Mutations, Ganciclovir Resistance, and Teratoma Formation in Human iPSCs Expressing an HSVtk Suicide Gene | Q34511951 | ||
| Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. | Q35055059 | ||
| Targeting of herpes simplex virus 1 thymidine kinase gene sequences into the OCT4 locus of human induced pluripotent stem cells | Q35060433 | ||
| Glycome diagnosis of human induced pluripotent stem cells using lectin microarray | Q35063280 | ||
| Molecular beacon-enabled purification of living cells by targeting cell type-specific mRNAs. | Q35077743 | ||
| Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells | Q35083934 | ||
| A new class of pluripotent stem cell cytotoxic small molecules | Q35125040 | ||
| Stem cells: balancing resistance and sensitivity to DNA damage | Q35128418 | ||
| Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies | Q35200156 | ||
| Brief reports: Controlling the survival of human pluripotent stem cells by small molecule-based targeting of topoisomerase II alpha. | Q35401202 | ||
| Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells | Q36229508 | ||
| A scalable approach to prevent teratoma formation of human embryonic stem cells | Q36294776 | ||
| Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants | Q36322764 | ||
| Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity | Q36379371 | ||
| Non-genetic Purification of Ventricular Cardiomyocytes from Differentiating Embryonic Stem Cells through Molecular Beacons Targeting IRX-4. | Q36379875 | ||
| Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency | Q36460656 | ||
| An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells | Q36510839 | ||
| Surviving the breakup: the DNA damage checkpoint. | Q36521813 | ||
| Mitochondria in human pluripotent stem cell apoptosis | Q36723084 | ||
| Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk | Q36861412 | ||
| Podocalyxin is a glycoprotein ligand of the human pluripotent stem cell-specific probe rBC2LCN. | Q36862054 | ||
| A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells. | Q36886793 | ||
| The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity | Q37021087 | ||
| Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse | Q37118996 | ||
| Hyperactivation of retina by light in mice leads to photoreceptor cell death mediated by VEGF and retinal pigment epithelium permeability | Q37148310 | ||
| Photodynamic Approach for Teratoma-Free Pluripotent Stem Cell Therapy Using CDy1 and Visible Light | Q37299031 | ||
| A medium hyperglycosylated podocalyxin enables noninvasive and quantitative detection of tumorigenic human pluripotent stem cells | Q37578885 | ||
| Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies | Q37666328 | ||
| Quality control: Genome maintenance in pluripotent stem cells | Q38180443 | ||
| Clinical-scale purification of pluripotent stem cell derivatives for cell-based therapies | Q38410411 | ||
| In situ label-free quantification of human pluripotent stem cells with electrochemical potential | Q38420981 | ||
| Stem Cell Therapies in Clinical Trials: Progress and Challenges | Q38542432 | ||
| Current status of pluripotent stem cells: moving the first therapies to the clinic. | Q38590664 | ||
| Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells | Q38780345 | ||
| CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation | Q38904477 | ||
| rBC2LCN, a new probe for live cell imaging of human pluripotent stem cells | Q39210038 | ||
| Human embryonic stem cells fail to activate CHK1 and commit to apoptosis in response to DNA replication stress | Q39354618 | ||
| Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders | Q39413565 | ||
| Antitumor activity of YM155, a selective small-molecule survivin suppressant, alone and in combination with docetaxel in human malignant melanoma models | Q39511072 | ||
| Protecting against wayward human induced pluripotent stem cells with a suicide gene | Q39660981 | ||
| Effect of duration and intensity of ganciclovir exposure on lymphoblastoid cell toxicity | Q39819129 | ||
| Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS). | Q39888778 | ||
| Identification of human embryonic stem cell surface markers by combined membrane-polysome translation state array analysis and immunotranscriptional profiling | Q39958444 | ||
| Neuron-like differentiation and selective ablation of undifferentiated embryonic stem cells containing suicide gene with Oct-4 promoter | Q39994542 | ||
| Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. | Q39999949 | ||
| A genetically encoded photosensitizer | Q40337535 | ||
| Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. | Q40466332 | ||
| MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells | Q41050244 | ||
| Novel surface-enhanced Raman scattering-based assays for ultra-sensitive detection of human pluripotent stem cells | Q41634297 | ||
| An inducible caspase 9 safety switch for T-cell therapy | Q41768001 | ||
| Human embryonic stem cells have constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis | Q41822569 | ||
| Quercetin induced ROS production triggers mitochondrial cell death of human embryonic stem cells. | Q42371490 | ||
| Molecular beacon-based detection and isolation of working-type cardiomyocytes derived from human pluripotent stem cells | Q42561001 | ||
| P433 | issue | 14 | |
| P921 | main subject | pluripotency | Q1894941 |
| cell death | Q2383867 | ||
| P304 | page(s) | 2601-2611 | |
| P577 | publication date | 2017-02-28 | |
| P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
| P1476 | title | Technical approaches to induce selective cell death of pluripotent stem cells | |
| P478 | volume | 74 |
| Q49719795 | Ceramide and S1P Signaling in Embryonic Stem Cell Differentiation |
| Q91673638 | Efficient Neural Differentiation of hPSCs by Extrinsic Signals Derived from Co-cultured Neural Stem or Precursor Cells |
| Q92469701 | Human Genomic Safe Harbors and the Suicide Gene-Based Safeguard System for iPSC-Based Cell Therapy |
| Q92466369 | In vivo surveillance and elimination of teratoma-forming human embryonic stem cells with monoclonal antibody 2448 targeting annexin A2 |
| Q90394592 | Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through p53-Mediated Apoptosis |
| Q65002709 | Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders. |
| Q57191372 | Selective Elimination of Culture-Adapted Human Embryonic Stem Cells with BH3 Mimetics |
| Q64996405 | Structure-Activity Relationship Analysis of YM155 for Inducing Selective Cell Death of Human Pluripotent Stem Cells. |
Search more.